Parkway Life REIT

CGS-CIMB's Lock Mun Yee has kept her target price at $5.06, while Citi’s Brandon Lee has maintained his target price of $5.02.

CGS-CIMB Group Research analyst downgraded PREIT from “add” to “hold” with an unchanged target price of $5.05

DBS and CGS-CIMB have raised their TPs to $5.75 and $5.05 respectively.

Parkway Life REIT gets an upgrade on clearer outlook.

IHH Healthcare CEO Kelvin Loh believes operating a big hospital group is in the interest of both patients and shareholders

Take a look at these six stocks this week, including Parkway Life REIT, Capitaland Mall Trust and Sembcorp Industries.

SINGAPORE (Sept 5): The SGX All Healthcare Index has reported a price gain of 2.7%, outperforming MSCI AC Asia ex Japan Health Care Index’s 1.9%, in terms of SGD.

SINGAPORE (May 29): UOB Kay Hian has raised target prices for Singapore real estate investment trusts (S-REITs) by an average of 8% on the back of a rosier economic outlook.

SINGAPORE (Feb 20): Parkway Life REIT has acquired four nursing homes and one dementia group nursing home in Japan from Marubeni Corporation, UBI Kabushiki Kaisha and UBI Capital Kabushiki Kaisha for JPY4.76 billion ($59.5 million).

SINGAPORE (Jan 27): DBS Group Research is maintaining its “buy” call on Parkway Life REIT (Plife REIT) with a target price of $2.75 as it offers one of the strongest earnings visibility profile among S-REITs, with a weighted average lease expiry of cl